Table 1. Patient characteristics in the... | American Society of Hematology

Table 1.

Patient characteristics in the ITT population

Characteristics	R (n = 77)		R + L (n = 77)
Characteristics	n	%	n	%
Median age (range), y	63 (29-85)		61 (26-80)
≥60 years old	49	64	42	55
≥70 years old	13	17	18	23
Sex
Male	37	48	35	45
Female	40	52	42	55
Ann Arbor stage
II	8	10	11	14
III	29	38	29	38
IV	40	52	37	48
Performance status
0	53	69	59	77
1	24	31	18	23
B symptoms
Absent	57	74	61	79
Present	20	26	16	21
LDH∗
Normal	59	77	60	78
>ULN	17	22	15	19
Missing	1	1	2	3
β2MG∗
Normal	40	52	43	56
>ULN / with >3mg/L	30/18	39/23	30/16	39/21
Missing	7	9	4	5
Bulky disease
<6 cm	46	60	45	58
≥6 cm	31	40	32	42
FLIPI score
Low risk	15	19	21	27
Intermediate risk	26	34	20	26
High risk	36	47	36	47
Histological grade
1	18	23	20	26
2	46	60	45	58
3A	13	17	12	16
PRIMA-PI
High risk	18	23	16	21
Low/intermediate risk	48	62	56	72
Missing	11	14	5	6

Characteristics	R (n = 77)		R + L (n = 77)
Characteristics	n	%	n	%
Median age (range), y	63 (29-85)		61 (26-80)
≥60 years old	49	64	42	55
≥70 years old	13	17	18	23
Sex
Male	37	48	35	45
Female	40	52	42	55
Ann Arbor stage
II	8	10	11	14
III	29	38	29	38
IV	40	52	37	48
Performance status
0	53	69	59	77
1	24	31	18	23
B symptoms
Absent	57	74	61	79
Present	20	26	16	21
LDH∗
Normal	59	77	60	78
>ULN	17	22	15	19
Missing	1	1	2	3
β2MG∗
Normal	40	52	43	56
>ULN / with >3mg/L	30/18	39/23	30/16	39/21
Missing	7	9	4	5
Bulky disease
<6 cm	46	60	45	58
≥6 cm	31	40	32	42
FLIPI score
Low risk	15	19	21	27
Intermediate risk	26	34	20	26
High risk	36	47	36	47
Histological grade
1	18	23	20	26
2	46	60	45	58
3A	13	17	12	16
PRIMA-PI
High risk	18	23	16	21
Low/intermediate risk	48	62	56	72
Missing	11	14	5	6

β2MG, beta-2 microglobulin; LDH, lactate dehydrogenase; ULN, upper limit of normal.

LDH and β2MG values were missing in 4 and 11 patients, respectively.